key: cord-0198212-13j5bx85
authors: Wu, Kai; Chugh, Vinit Kumar; Krishna, Venkatramana D.; Girolamo, Arturo di; Wang, Yongqiang Andrew; Saha, Renata; Liang, Shuang; Cheeran, Maxim C-J; Wang, Jian-Ping
title: One-step, Wash-free, Nanoparticle Clustering-based Magnetic Particle Spectroscopy (MPS) Bioassay Method for Detection of SARS-CoV-2 Spike and Nucleocapsid Proteins in Liquid Phase
date: 2021-08-01
journal: nan
DOI: nan
sha: c950022712b7d4a87b128a601f1ec8f4f8aaa79e
doc_id: 198212
cord_uid: 13j5bx85

With the ongoing global pandemic of coronavirus disease 2019 (COVID-19), there is an increasing quest for more accessible, easy-to-use, rapid, inexpensive, and high accuracy diagnostic tools. Traditional disease diagnostic methods such as qRT-PCR (quantitative reverse transcription-PCR) and ELISA (enzyme-linked immunosorbent assay) require multiple steps, trained technicians, and long turnaround time that may worsen the disease surveillance and pandemic control. In sight of this situation, a rapid, one-step, easy-to-use, and high accuracy diagnostic platform will be valuable for future epidemic control especially for regions with scarce medical resources. Herein, we report a magnetic particle spectroscopy (MPS) platform for detection of SARS-CoV-2 biomarkers: spike and nucleocapsid proteins.

substances including protein molecules, aptamers, and other non-magnetic materials onto MNPs can hinder or even block this Brownian relaxation. 23, 27, [38] [39] [40] [41] [42] [43] [44] [45] As a result, this binding event causes a phase lag between magnetic moments and external AC fields (except at very low frequencies) and thus, weaker dynamic magnetic responses are observed from clustered MNPs. By exploiting this unique property of Brownian relaxation-dominant MNPs, researchers have applied it along with MPS platform for the detection of H1N1 virus 39 , thrombin 38 , staphylococcal toxins 20 , SARS-CoV-2 23, 46 , botulinum neurotoxins A, B, and E 21 , etc. Compared to the traditional optical, mechanical, and electrochemical sensing techniques, this magnetic sensing technique is immune to the background noise from biological samples that may interfere with the signal reading since most biological substrates are non-magnetic (or paramagnetic) and MNPs are the only sources of magnetic signal.

Our group has successfully built up both benchtop and portable MPS systems for one-step, wash-free bioassays. 22, 39 In this paper, we have modified the MPS system to include a one-stage lock-in scheme for the advantages of down sampling and phase sensitive rejection of noise. Herein, we report a one-step, wash-free, nanoparticle clustering-based MPS bioassay method for the detection of SARS-CoV-2 spike and nucleocapsid proteins in liquid phase using this one-stage lock-in MPS system. By surface conjugating polyclonal antibodies (pAbs) to MNPs, each MNP will be able to specifically bind to targe protein molecules. On the other hand, each protein molecule has multiple epitopes that allows the specific bindings of pAbs. Thus, the pAbs anchored to MNP surfaces and the nature of different epitopes from each protein molecule allows us to amplify the binding events caused dynamic magnetic responses change. We demonstrate that this nanoparticle clustering-based detection method can detect target analytes by monitoring the dynamic magnetic responses of MNPs. and coercivity (Hc). The static magnetic hysteresis loops of IPG30 MNPs are measured under external fields of -5000 -5000 Oe and -500 -500 Oe, and the magnetic properties are analyzed in the Supporting Information S1.

2.3. One-stage Lock-in Magnetic Particle Spectroscopy (MPS) System. The MPS platform used in this work utilizes frequency mixing approach where the excitation magnetic field consists of a low-frequency (fL) component and a high-frequency (fH) component. 17, [19] [20] [21] [22] 26, 39, 43 A low frequency field having 50 Hz frequency, 250 Oe amplitude and a high-frequency field having 5000 Hz frequency, 25 Oe amplitude were used for the magnetic excitation of the MNPs. In this work, the MPS system is modified with the addition of a one-stage lockin implementation to improve the detection sensitivity of the system. 

The MPS-based bioassays for detection of target analytes in liquid phase allows for one-step, wash-free assays that can be handled by a layperson without much technical training requirements. This method relies on the intentional interference on the Brownian relaxation of MNPs in liquid.

When subjected to external AC magnetic fields (excitation fields), the magnetic moments of MNPs try to re-align to external field directions though the Brownian relaxation. This process will be hindered if MNPs are surface bound with polymers, protein molecules (such as antibody, antigen), aptamers, etc. 18, 23, 26, 38 , fixed on a surface/substrate 20, 21, 46, 47 , or form nanoparticle clusters 26, 38, 39 . Figure 2 (b) shows a schematic view that by surface coating an increased number of antibodies, the dynamic magnetic responses of MNPs (in the form of MPS spectra, i.e., the amplitudes of higher harmonics) become weaker. In the presence of target analytes, the antibody functionalized MNPs bind to these analytes and form nanoparticle clusters. As a result, this nanoparticle clustering events further weaken the dynamic magnetic response and thus, lowering the harmonic amplitudes, as shown in 

Groups. We firstly evaluated the detection limit of our one-stage lock-in MPS system for the detection of IPG30 MNPs. Samples containing a varying concentration/amount of IPG30 MNPs are prepared by two-fold dilutions as shown in Table S1 from Supporting Information S2. Three independent MPS readings are taken from each sample and the amplitudes of higher harmonics are summarized in Figure S2 from Supporting Information S2. Results show that the developed one-stage lock-in topology-based MPS system can detect as low as 266 ng (equal to 9 fmole) of IPG30 MNPs, which equals to 512-fold dilutions of the original concentration. Compared with our previous work, this modified MPS system has higher detection sensitivity. 22, 26, 39 Thus, for the bioassays in this work, we used diluted IPG30 MNPs with final particle concentration of 3.06 nM and weight concentration of 90 μg/mL. This feasibility attempt allows us to explore inexpensive bioassays on our MPS platform for future high-volume tests at the users' ends as well as in regions with scarce medical resources. Furthermore, it is reported that for MPS-based homogeneous bioassays, lower MNP concentrations could improve the detection sensitivities of biomolecules. 24, 48 The design of one-step, wash-free, nanoparticle clustering-based MPS bioassays is highly relied on the surface functionalization of polyclonal antibodies (pAbs) on MNPs. It has been reported in our previous work that the pAbs functionalized on MNPs can trigger the cross-linking between MNPs and target analytes thus, forming MNP clusters. 39 In this work, the SARS-CoV-2 spike and nucleocapsid proteins have multiple epitopes that can be recognized by their corresponding pAbs. As a result, each protein molecule (i.e., spike and nucleocapsid) can bind to multiple pAbs from multiple MNPs. On the other hand, each MNP functionalized with multiple pAbs can bind to multiple protein molecules. A schematic example is given in Figure 2 Table 1 . For the SARS-CoV-2 spike protein tests, we prepared 4 groups of samples along with one negative control sample (vial #9) that contains bare IPG30 MNP without pAb coating (labeled as 'bare MNP' in this work). In each group, the vials #X-8 (X=I, II, III, and IV) serve as the negative control that contain MNPs functionalized with varying amount of pAbs while 0 nM of protein (we replaced the protein with PBS buffer) is added. Thus, a total of 33 samples for SARS-CoV-2 spike protein and 33 samples for nucleocapsid protein tests are prepared, respectively.

As shown in Figure 2 (a), the diluted IPG30 MNPs (particle concentration of 3.06 nM) are incubated with spike or nucleocapsid pAbs for 12 hours at 4 °C on incubating shaker. This step allows the Fc part of IgG pAbs to bind to protein G from IPG30 MNP surfaces. Then 80 μL of pAb functionalized MNPs is mixed with 80 μL of spike or nucleocapsid proteins and incubated at room temperature for 1 hour with continuous shaking. After this point, the specific binding between pAbs and target protein molecules reaches to an equilibrium state, sample vials are then stored at 4 °C before MPS tests. It should be noted that the 1-hour incubation time of pAb functionalized MNPs with protein biomarkers is not optimized. To ensure the antibody-antigen binding to fully saturate, we set an incubation time of 1 hour. Further works should be carried out to reduce the incubation time by means of changing incubation conditions (such as temperature 49, 50 , pressure 51 , flow rate 52 , etc) or choosing higher binding affinity pAbs 53 . Higher harmonics such as the 3 rd , the 5 th , the 7 th , the 9 th , the 11 th harmonics are labeled in (c). Dotted lines have been added to help guide the view to compare the relative intensities of harmonics between the four sets of data. Figure 4 (i) proves the schematic drawing in Figure 2 (b) that functionalizing more pAbs per MNP will cause weaker dynamic magnetic responses and lower harmonic signals. Which also confirms that the pAbs have been successfully functionalized onto IPG30 MNPs. *** p < 0.001; ** p < 0.01; * p <0.05.

From the concentration-response profiles of SARS-CoV-2 spike protein, it is concluded that functionalizing three pAbs per MNP (Group II, MNP:pAb=1:3, Figure 4 (b)) gives us the best linear response curve with a detection limit of 1.56 nM (equivalent to 125 fmole of spike protein molecules).

In Figure 5 , we have summarized the ratios of higher harmonics (from the 5 th to the 15 th harmonics) to the 3 rd harmonics collected from each sample. For Groups I, III, and IV ( Figure 5(a) , (c), and (d)), the harmonic ratio curves of vials #X-1 to #X-8 (X=I, III, and IV) are tightly distributed with very narrow gaps or even overlapping.

While the harmonic ratio curves from Group II vials #II-1 to #II-8 are sparsely distributed. The significant differences in harmonic ratio curves from vials added with different concentration/amount of spike protein molecules allow us to analyze and collect meaningful concentration-response profiles as shown in Figure 4 (b).

The harmonic amplitude decreases as the harmonic index increases, namely, the harmonic amplitudes A3 > A5 > A7 > A9 > A11 > A13 > A15, where A represents amplitude (A). It is observed that functionalizing different amount of pAbs per MNP also changes the decay rate of higher harmonics (with harmonic index), as reflected in the MPS spectra from Figure 3 (c). The yellow double arrows in Figure 5 (ad) mark the decay rates from the 5 th to the 3 rd harmonics across groups I to IV. In average, the R53 (harmonic amplitude ratio of A5 over the A3) from Yellow double arrows mark the decay rate from the 5 th to the 3 rd harmonics across groups I to IV.

Besides comparing each sample's higher harmonic amplitudes (A5 -A15) to its own 3 rd harmonic (A3). We further compared the samples' higher harmonics from Group I -IV with the bare MNP sample (vial #9, IPG30

MNP without any surface functionalization). As shown in Supporting Information S4, the 3 rd , 5 th , 7 th , 9 th , 11 th , 13 th , and 15 th harmonics of each sample is compared with the corresponding harmonics from bare MNP sample Figure 4 (ei). Thus, ideally, the color becomes darker from left column to right column in each grayscale heatmap (as schemed in Figure 6 (b)). In each column of Figure 6 (a), with IPG30 MNPs surface functionalized with an identical number of pAbs, adding more spike protein causes larger harmonic signal drop.

Ideally, the color becomes darker from the bottom row (vials #X-1, X=I, II, III, and IV) to the top row (vials #X-8, X=I, II, III, and IV). Again, this ideal trend is schemed in Figure 6 (b). 

Herein, we have successfully applied a one-stage lock-in MPS system for the detection of SARS-CoV-2 spike and nucleocapsid proteins directly in liquid phase. This one-step, wash-free detection method allows a layperson to carry out the tests without much technical training requirements. By conjugating pAbs to MNPs, it increases the chances of MNP binding events to target protein molecules (i.e., spike and nucleocapsid proteins in this work).

Combined with the nature that each protein molecule has different epitopes that allow the binding of multiple pAbs. We are able to amply the effect of MNP binding events caused obstruction of physical rotational motion of MNPs and thus, amplifying the changes in higher harmonics.

In It should also be noted that the results presented in this work are based on detecting purified spike and nucleocapsid proteins from PBS buffer. This is a feasibility demonstration of one-stage lock-in MPS system for protein biomarker detection, we did not measure SARS-CoV-2 biomarkers from clinical samples such as upper respiratory tract mucus including saliva and sputum. There are several factors that may impair the sensitivity and repeatability of MPS platforms when testing clinical samples, such as viscosity of biofluid samples, temperature, and nonspecific binding of unknown chemical compounds from biofluids. Since this one-step liquid phase detection mechanism relies on the binding events-caused Brownian relaxation change in MNPs, the viscosity and temperature of biofluid samples can cause different degrees of deviations in MPS harmonic signals, and the nonspecific binding can cause repeatability issues (as well as false positive results). To avoid the viscosity variation caused MPS signal bias, several samples preparation and collection methods can be adopted. Such as using exhaled breath condensate (EBC) that contains respiratory droplets from the lower respiratory tract. [54] [55] [56] The condensed water droplets containing SARS-CoV-2 virions can effectively avoid the body fluid (i.e., sputum, saliva) caused viscosity variations between patients. In addition to the sample collection method, the sample preparation method can also be altered for this specific application. Usually, the upper respiratory tract mucus samples (nasopharyngeal swabs, throat swabs, nasopharyngeal wash, saliva, sputum, etc) have high virus titer but the complex internal matrix could interfere the MPS test results due to the high viscosity and unknown chemical compounds that nonspecifically bind to MNPs. 57, 58 The binding specificities of pAbs used in this work have been confirmed by ELISA testing (see Supporting Information S7). A mature sample preparation process has been applied to dilute specimens by washing buffers and filter out larger particle complexes. 59 The minimum detectable amount of IPG30 MNPs by our homebuilt MPS system is firstly investigated by twofold dilutions of IPG30. There are a total of 13 vials prepared each contains 80 μL IPG30 of varying degrees of dilutions, and vial #13 is a blank sample for control purpose, as shown in Table S1 . Three independent MPS readings are taken on each sample and the higher harmonics (the 3 rd , 5 th , 7 th , and 9 th ) are summarized in Figure   S2 . Overall, the harmonic signal amplitudes decrease linearly as we decrease the amount of IPG30 MNPs in the vial. The figure insets zoom in the harmonic amplitudes of vials that contain less than 1 μg of IPG30 MNPs. All of the 3 rd , the 5 th , and the 7 th harmonics show the detection limit of IPG30 MNPs is at 265 ng (vial #10, 512-fold dilution), which equals to 9 fmole of IPG30 nanoparticles. In order to cut down the cost per assay and make MPS an inexpensive platform for high volume bioassays in the future, we explored the feasibility of using 20-fold diluted IPG30 for detection of SARS-CoV-2 nucleocapsid and spike proteins in this paper. The functionalization of different amount of pAbs will inevitably hinder the Brownian relaxation of MNPs, thus, with more pAbs functionalized on each MNP, the weaker magnetic responses (refelected in the MPS harmonic amplitudes) will be observed. As summarized in Table S2, The colloidal stability of bare MNPs is compared with MNPs functionalized with pAbs. It is confirmed that the MNP suspensions show a neutral to slightly alkaline pH of 7.0 -7.1. As shown in Table S2 , with the functionalization of pAbs, the zeta potential barely changes. Thus, functionalizing pAbs to MNPs won't affect the stability of MNPs. the subscripts are sample indexes, X=I, II, III, and IV, =1, 2, 3, …, 8) are plotted. In each row of Figure S4 (ag), by adding the same amount of spike protein molecules, the harmonic signal drop ∆ decreases from I to IV, which agrees with the results in Figure 4 (ei). Thus, ideally, the color becomes darker from left column to right column in each grayscale heatmap (as schemed in Figure S4 (h)). In each column of Figure S4 (ag), with IPG30 MNPs surface functionalized with an identical number of pAbs, adding more spike protein causes larger harmonic signal drop. Thus, ideally, the color becomes darker from the bottom row (vials #X-1, X=I, II, III, and IV) to the top row (vials #X-8, X=I, II, III, and IV). Again, this ideal trend is schemed in Figure S4 (h). The 3 rd harmonics give highest signal to noise ratio (SNR), and we can clearly see this trend from Figure S4 (a). Figure S4 (a1 -a4) plots the 3 rd harmonic signal drop ∆ curves for samples from Groups I -IV, where Group II shows the best monotonic concentration-response curve. Figure S4 

S6. The ratios of higher harmonics to the 3 rd harmonics recorded from groups I to IV for SARS-CoV-2 nucleocapsid protein.

The ratios of higher harmonics (from the 5 th to the 15 th harmonics) to the 3 rd harmonics collected from each sample for SARS-CoV-2 nucleocapsid protein detection. As shown in Figure S6 , for Group I, the harmonic ratio curves from samples #I-1 to #I-8 are sparsely distributed. The significant differences in harmonic ratio curves from vials added with different concentration/amount of nucleocapsid protein molecules allow us to analyze and collect meaningful concentration-response profiles as shown in Figure 7 (a). However, for groups II and III, the harmonic ratio curves are tightly distributed with very narrow gaps or even overlapping. Indicating very small differences in harmonic signals for samples in Groups II and III, as shown in Figure 7 For SARS-CoV-2 nucleocapsid protein detection.

A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin

Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan

Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding

Genomic Characterization of the 2019 Novel Human-Pathogenic Coronavirus Isolated from a Patient with Atypical Pneumonia after Visiting Wuhan

A New Coronavirus Associated with Human Respiratory Disease in China

A Novel Coronavirus from Patients with Pneumonia in China

Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection

Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2

COVID-19 Diagnosis-A Review of Current Methods

Molecular Diagnosis of a Novel Coronavirus (2019-NCoV) Causing an Outbreak of Pneumonia

Laboratory Diagnosis of Emerging Human Coronavirus Infections-the State of the Art

Evaluation of a Novel Antigen-Based Rapid Detection Test for the Diagnosis of SARS-CoV-2 in Respiratory Samples

Development of a Portable, Ultra-Rapid and Ultra-Sensitive Cell-Based Biosensor for the Direct Detection of the SARS-CoV-2 S1 Spike Protein Antigen

Microfluidic Immunoassays for Sensitive and Simultaneous Detection of IgG/IgM/Antigen of SARS-CoV-2 within 15 Min

Evaluation of Rapid Antigen Test for Detection of SARS-CoV-2 Virus

Magnetic Particle Spectroscopy: A Short Review of Applications Using Magnetic Nanoparticles

New Type of Biosensor Based on Magnetic Nanoparticle Detection

Magnetic Particle Spectroscopy-Based Bioassays: Methods, Applications, Advances, and Future Opportunities

Magnetic Particle Detection by Frequency Mixing for Immunoassay Applications

Magnetic Immunoassay for Detection of Staphylococcal Toxins in Complex Media

Multiplex Biosensing Based on Highly Sensitive Magnetic Nanolabel Quantification: Rapid Detection of Botulinum Neurotoxins A, B, and E in Liquids

A Portable Magnetic Particle Spectrometer for Future Rapid and Wash-Free Bioassays

Toward Rapid and Sensitive Detection of SARS-CoV-2 with Functionalized Magnetic Nanoparticles

Dependence of Biomolecule Detection on Magnetic Nanoparticle Concentration

Characterizing Physical Properties of Superparamagnetic Nanoparticles in Liquid Phase Using Brownian Relaxation

Magnetic Nanoparticle Relaxation Dynamics-Based Magnetic Particle Spectroscopy for Rapid and Wash-Free Molecular Sensing

Measuring Protein Biomarker Concentrations Using Antibody Tagged Magnetic Nanoparticles

Using Magnetic Nanoparticles and Protein-Protein Interactions to Measure PH at the Nanoscale

Quantification of Magnetic Nanoparticles by Compensating for Multiple Environment Changes Simultaneously

Biological Sensors Based on Brownian Relaxation of Magnetic Nanoparticles

Real-Time Measurement of Brownian Relaxation of Magnetic Nanoparticles by a Mixing-Frequency Method

Magnetic Dynamics of Ferrofluids: Mathematical Models and Experimental Investigations

Simulations of Magnetic Nanoparticle Brownian Motion

Coupled Stochastic Dynamics of Magnetic Moment and Anisotropy Axis of a Magnetic Nanoparticle

Effects of Size and Anisotropy of Magnetic Nanoparticles Associated with Dynamics of Easy Axis for Magnetic Particle Imaging

The Role of Anisotropy in Distinguishing Domination of Néel or Brownian Relaxation Contribution to Magnetic Inductive Heating: Orientations for Biomedical Applications

Effects of Particle Diameter and Magnetocrystalline Anisotropy on Magnetic Relaxation and Magnetic Particle Imaging Performance of Magnetic Nanoparticles

Molecular Sensing with Magnetic Nanoparticles Using Magnetic Spectroscopy of Nanoparticle Brownian Motion

Magnetic Particle Spectroscopy for Detection of Influenza A Virus Subtype H1N1

Multiplex Label-Free Biosensor for Detection of Autoantibodies in Human Serum: Tool for New Kinetics-Based Diagnostics of Autoimmune Diseases

Evaluating Blood Clot Progression Using Magnetic Particle Spectroscopy

Blood Clot Detection Using Magnetic Nanoparticles

Multiplex Biosensing with Highly Sensitive Magnetic Nanoparticle Quantification Method

Highly Reproducible and Sensitive Detection of Mycotoxins by Label-Free Biosensors

Ultrasensitive Quantitative Detection of Small Molecules with Rapid Lateral-Flow Assay Based on High-Affinity Bifunctional Ligand and Magnetic Nanolabels

Brief Communication: Magnetic Immuno-Detection of SARS-CoV-2 Specific Antibodies

Nanomagnetic Lateral Flow Assay for High-Precision Quantification of Diagnostically Relevant Concentrations of Serum TSH

Magnetic Particle Spectroscopy (MPS) with One-Stage Lock-in Implementation for Magnetic Bioassays with Improved Sensitivities. ArXiv Prepr

Deoxyribonucleic Acid Homology in Bacterial Taxonomy: Effect of Incubation Temperature on Reaction Specificity

Unbinding Forces of Single Antibody-Antigen Complexes Correlate with Their Thermal Dissociation Rates

Use of High Pressure to Accelerate Antibody: Antigen Binding Kinetics Demonstrated in an HIV-1 P24: Anti-HIV-1 P24 Assay

Accelerated Surface-Enhanced Raman Spectroscopy (SERS)-Based Immunoassay on a Gold-Plated Membrane

Kinetic Analysis of a High-Affinity Antibody/Antigen Interaction Performed by Planar Waveguide Fluorescence Immunosensor

Breath Diagnostics in the Era of SARS-CoV-2-Clinical and Research Arena

Use of Exhaled Breath Condensate (EBC) in the Diagnosis of SARS-COV-2 (COVID-19)

Detecting SARS-CoV-2 in the Breath of COVID-19 Patients

A Mathematical Model Describing the Localization and Spread of Influenza A Virus Infection within the Human Respiratory Tract

Respiratory Droplet Generation and Dispersal during Nasoendoscopy and Upper Respiratory Swab Testing

Fully Packaged Portable Thin Film Biosensor for the Direct Detection of Highly Pathogenic Viruses from On-Site Samples

Multiplexed Detection of Influenza A Virus Subtype H5 and H9 via Quantum Dot-Based Immunoassay

Rapid Enrichment and Ultrasensitive Detection of Influenza A Virus in Human Specimen Using Magnetic Quantum Dot Nanobeads Based Test Strips

Effect of Antigen Retrieval Methods on Nonspecific Binding of Antibody-Metal Nanoparticle Conjugates on Formalin-Fixed Paraffin-Embedded Tissue

A Dense Poly (Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles within Brain Tissue

Minimizing the Non-Specific Binding of Nanoparticles to the Brain Enables Active Targeting of Fn14-Positive Glioblastoma Cells

United States c Ocean Nano Tech LLC

Static magnetic hysteresis loops and magnetic properties of IPG30 MNPs

The static magnetic hysteresis loops are collected from air-dried 10 μL IPG30 MNP and the magnetizations are calculated based on its weight concentration. As shown in Figure S1, magnetic fields are swept from -5000 Oe to +5000 Oe for Figure S1(a), and from -500

Due to the surface coating layer of protein G, the inter-particle distance is increased thus, this small coercivity field does not cause the clustering or sedimentation of MNPs

Static magnetic hysteresis loops of air-dried IPG30 MNPs measured by a PPMS. The field range is (a)

Specificity of SARS-CoV-2 spike and nucleocapsid pAbs confirmed by ELISA

Microtiter wells were coated with Rabbit anti-Spike-RBD (for Spike ELISA) or rabbit anti-Nucleiocapsid (for nucleocapsid ELISA) as capture antibody and detected using corresponding biotin conjugated rabbit polyclonal antibodies and streptavidin-HRP

The binding specificities of pAbs are confirmed by testing four different SARS-CoV-2 isolates and four other coronaviruses using ELISA